These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18823758)

  • 1. Dipeptidyl peptidase II is not a marker for progression in melanoma.
    Fröhlich E; Maier E; Mack AF; Garbe C
    J Dermatol Sci; 2009 Jan; 53(1):68-71. PubMed ID: 18823758
    [No Abstract]   [Full Text] [Related]  

  • 2. Human malignant melanoma harbours a large fraction of highly clonogenic cells that do not express markers associated with cancer stem cells.
    Prasmickaite L; Skrbo N; Høifødt HK; Suo Z; Engebråten O; Gullestad HP; Aamdal S; Fodstad Ø; Maelandsmo GM
    Pigment Cell Melanoma Res; 2010 Jun; 23(3):449-51. PubMed ID: 20236249
    [No Abstract]   [Full Text] [Related]  

  • 3. Overexpression of matrix metalloproteinases, chemokines, and chemokine receptors relevant for metastasis in experimental models not an indication of lymph node metastases in human melanoma.
    Otto K; Starz H; Becker JC; Schrama D
    Arch Dermatol; 2007 Jul; 143(7):947-8. PubMed ID: 17638747
    [No Abstract]   [Full Text] [Related]  

  • 4. The dipeptidyl peptidase IV family in cancer and cell biology.
    Yu DM; Yao TW; Chowdhury S; Nadvi NA; Osborne B; Church WB; McCaughan GW; Gorrell MD
    FEBS J; 2010 Mar; 277(5):1126-44. PubMed ID: 20074209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma progression in a changing environment.
    van Kempen LC; van Muijen GN; Ruiter DJ
    Eur J Cell Biol; 2007 Feb; 86(2):65-7. PubMed ID: 17241688
    [No Abstract]   [Full Text] [Related]  

  • 6. Tenascin C: a defensive role in sentinel lymph nodes of melanoma patients?
    Gazzaniga P; Cigna E; Vincenzi B; Bottoni U; Vasaturo F; Alfano C; Calvieri S; Frati L; Scuderi N; Aglianò AM; Gradilone A
    J Dermatol Sci; 2009 Mar; 53(3):239-41. PubMed ID: 19070467
    [No Abstract]   [Full Text] [Related]  

  • 7. MicroRNAs in malignant melanoma.
    Völler D; Ott C; Bosserhoff A
    Clin Biochem; 2013 Jul; 46(10-11):909-17. PubMed ID: 23360785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A trip through the signaling pathways of melanoma].
    Fensterle J
    J Dtsch Dermatol Ges; 2006 Mar; 4(3):205-17. PubMed ID: 16626317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How far can we trust cell cycle biomarkers for the identification of high-risk melanoma patients?
    Simonart T; Heenen M
    J Cutan Pathol; 2005 May; 32(5):383-4. PubMed ID: 15811127
    [No Abstract]   [Full Text] [Related]  

  • 10. Ala657 and conserved active site residues promote fibroblast activation protein endopeptidase activity via distinct mechanisms of transition state stabilization.
    Meadows SA; Edosada CY; Mayeda M; Tran T; Quan C; Raab H; Wiesmann C; Wolf BB
    Biochemistry; 2007 Apr; 46(15):4598-605. PubMed ID: 17381073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 1 antichymotrypsin is aberrantly expressed during melanoma progression and predicts poor survival for patients with metastatic melanoma.
    Wang Y; Jiang H; Dai D; Su M; Martinka M; Brasher P; Zhang Y; McLean D; Zhang J; Ip W; Li G; Zhang X; Zhou Y
    Pigment Cell Melanoma Res; 2010 Aug; 23(4):575-8. PubMed ID: 20444200
    [No Abstract]   [Full Text] [Related]  

  • 12. Melanoma-associated markers expression in blood: MUC-18 is associated with advanced stages in melanoma patients.
    Rapanotti MC; Bianchi L; Ricozzi I; Campione E; Pierantozzi A; Orlandi A; Chimenti S; Federici G; Bernardini S
    Br J Dermatol; 2009 Feb; 160(2):338-44. PubMed ID: 19067715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis.
    Martins I; Sylla K; Deshayes F; Lauriol J; Ghislin S; Dieu-Nosjean MC; Viguier M; Verola O; Charron D; Alcaide-Loridan C; Al-Daccak R
    Melanoma Res; 2009 Aug; 19(4):226-37. PubMed ID: 19574933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of neoplastic cells in the lymphocytic infiltrate associated with thin melanomas.
    Salvio AG; Ribeiro DA; Marques ME
    Histopathology; 2007 Jun; 50(7):942-4. PubMed ID: 17543085
    [No Abstract]   [Full Text] [Related]  

  • 15. PAX4 has the potential to function as a tumor suppressor in human melanoma.
    Hata S; Hamada J; Maeda K; Murai T; Tada M; Furukawa H; Tsutsumida A; Saito A; Yamamoto Y; Moriuchi T
    Int J Oncol; 2008 Nov; 33(5):1065-71. PubMed ID: 18949370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma.
    Zhuang L; Scolyer RA; Lee CS; McCarthy SW; Cooper WA; Zhang XD; Thompson JF; Hersey P
    Histopathology; 2009 Mar; 54(4):462-70. PubMed ID: 19309398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin layer-specific Melan-A expression during progression of human cutaneous melanoma: implications for diagnostic applications of the marker.
    Sztramska A; Dymerska D; Chwirot BW
    Melanoma Res; 2008 Aug; 18(4):259-67. PubMed ID: 18626310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
    Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A
    Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-221 and -222 pathway controls melanoma progression.
    Felicetti F; Errico MC; Segnalini P; Mattia G; Carè A
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1759-65. PubMed ID: 18983236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
    Petersson S; Shubbar E; Enerbäck L; Enerbäck C
    Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.